Qlife Holding AB (publ)

Stockholm Stock Exchange QLIFE.ST

Qlife Holding AB (publ) Market Capitalization on January 14, 2025: USD 1.33 M

Qlife Holding AB (publ) Market Capitalization is USD 1.33 M on January 14, 2025, a 85,201.39% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Qlife Holding AB (publ) 52-week high Market Capitalization is USD 2.26 M on September 05, 2024, which is 69.46% above the current Market Capitalization.
Qlife Holding AB (publ) 52-week low Market Capitalization is USD 403.89 on June 28, 2024, which is -99.97% below the current Market Capitalization.
Qlife Holding AB (publ) average Market Capitalization for the last 52 weeks is USD 884.54 K.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Stockholm Stock Exchange: QLIFE.ST

Qlife Holding AB (publ)

CEO	Mr. Thomas Warthoe
IPO Date	March 2, 2020
Location	Sweden
Headquarters	Redaregatan 48
Employees	24
Sector	Health Care
Industries Pharmaceuticals Biotechnology Medical Instruments

Description

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.

Key trends

Past 5 years